In August 2015 the US Food and Drug Administration approved Flibanserin to treat a condition called Hypoactive Sexual Interest / Arousal Disorder (HSDD) in premenopausal women. HSDD is considered a type of sexual dysfunction. It is recognized that sexual dysfunction can refer to difficulties in libido (sex drive), arousal and orgasm. Many causes can lead to sexual dysfunction including life stressors, medical conditions and medications. Addressing these conditions first may help HSDD. Flibanserin works by interacting with certain receptors for serotonin which regulate mood, sleep, and digestion among many functions in the body. Researchers are not sure how Flibanserin leads to improved sexual desire in women but studies have shown that it has a beneficial effect in women diagnosed with HSDD. The pill is taken daily and side effects include sleepiness, decreased blood pressure and fainting. The pill should not be taken with alcohol.
It is important to note that the Flibanserin medication is for premenopausal patients. Most patients we see who have pain with intercourse that leads to decreased desire are postmenopausal. These patients suffer from Genital Atrophy Syndrome (GAS). Some premenopausal may also have atrophy symptoms. A pill will not change the atrophy that leads to their suffering. The GAS that leads to suffering can be changed with a laser. We offer the Mona Lisa Touch laser treatment. This resolves the pain from atrophy that leads to decreased pleasurable intercourse. Patients who have no estrogen or cannot take estrogen (Breast Cancer Patients) are ideal and see great results. It is amazing that a simple, painless office procedure improves the intimate relationships and overall sense of wellness for our patients.